Active, Not Recruiting
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
NCT02914405
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital Madison, Wisconsin, United States
- University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
- University College London Hospital London, United Kingdom